Abstract. The More than a decade ago, the plasma C-peptide re¬ sponse to 1 mg glucagon iv was introduced as an estimate of islet B-cell function in insulin-depen¬ dent diabetes mellitus (IDDM) (1). The plasma C-peptide response to iv glucagon reaches a max¬ imum after 6 min and is of a similar magnitude as the response to a standard test meal. The plasma C-peptide concentration 6 min after iv injection of 1 mg glucagon has, therefore, gained use as an estimate of residual B-cell function in IDDM (2-10).
Abstract. The dose-response relationships between prestimulatory blood glucose concentration and the plasma C-peptide responses to stimulation with 1 mg of glucagon iv or a standard mixed meal were studied in 8 C-peptide positive patients with insulin-dependent diabetes mellitus. Hyperglycemia was maintained for 90 min before stimulation using a hyperglycemic clamp technique. Each test was performed at the steady state blood glucose levels~5 ,~12, and~20 mmol/l. The glucose potentiation of the incremental plasma C-peptide area under the curve at the two levels of hyperglycemia in percent of the area at normoglycemia (median and range) was 343% (53-1053) (p<0.05) and 341% (267-1027) (p<0.05) after glucagon and 140% (76-227) (NS) and 251% (95-1700) (p<0.05) after the meal. The corresponding relative glucose potentiation of plasma C-peptide 6 min after stimulation with glucagon was 124% (100\ x=req-\ 427) (p<0.02) and 144% (100-209) (p<0.05). There was no significant difference in the degree of glucose potentiation at~12 or~2 0 mmol/l. Furthermore, there was no significant difference in the degree of glucose potentiation of the different estimated values of B-cell function.
In conclusion, the plasma C-peptide responses to iv glucagon or to a standard test meal were markedly potentiated by acute hyperglycemia in insulin-dependent diabetes mellitus. No further potentiation was, however, obtained when the prestimulatory blood glucose concentration was raised above 12 mmol/l. These findings con- trast those reported in non-insulin-dependent diabetes, where endogenous insulin secretion is potentiated further when the blood glucose concentration is raised tõ 20 mmol/l.
More than a decade ago, the plasma C-peptide re¬ sponse to 1 mg glucagon iv was introduced as an estimate of islet B-cell function in insulin-depen¬ dent diabetes mellitus (IDDM) (1) . The plasma C-peptide response to iv glucagon reaches a max¬ imum after 6 min and is of a similar magnitude as the response to a standard test meal. The plasma C-peptide concentration 6 min after iv injection of 1 mg glucagon has, therefore, gained use as an estimate of residual B-cell function in IDDM (2-10).
By applying the hyperglycémie clamp technique (11) , a very pronounced potentiation of B-cell re¬ sponsiveness to both glucose and other secretagogues is induced by acute hyperglycemia in noninsulin-dependent diabetes mellitus (NIDDM), with a continued potentiation along with an in¬ crease in prestimulatory blood glucose concentra¬ tion from normoglycemia to 20-25 mmol/1 (12, 13) .
In IDDM, the B-cell responsiveness also depends on the concomitant blood glucose concentration (2,3). However, the degree of potentiation induced by different levels of hyperglycemia is not known. Hence, the aim of the present study was Fig. 2 shows the dose-response relationship be¬ tween increasing prestimulatory blood glucose con¬ centrations and the concentrations of prestimulatory plasma C-peptide and of plasma C-peptide 6 min after glucagon stimulation. Fig. 3 shows the same dose-response relationship, employing incre¬ mental areas under the plasma C-peptide curve after glucagon or the meal as estimates of B-cell function. In Table 1 , glucose potentiation of esti¬ mated B-cell function is expressed as results at hy¬ perglycemia in per cent of results at normoglyce¬ mia. The estimated B-cell function was in all cases significantly potentiated by prestimulatory hy¬ perglycemia (Table 1) . However, the estimated B-cell function was in no case significantly more potentiated at -20 mmol/1 than at~12 mmol/1 (Fig.  1, Fig. 2 Relative glucose potentiation of estimated B-cell fonction expressed as results at prestimulatory hyperglycemia in percentage of results at prestimulatory normoglycemia (median and ranges). (17) (18) (19) (20) .
In this study, prestimulatory plasma C-peptide and plasma C-peptide 6 min post glucagon showed a similar degree of glucose potentiation. A similar dependency on the prestimulatory blood glucose concentration agrees well with previous reports suggesting that basal plasma C-peptide and plasma C-peptide 6 min post glucagon basically contain the same information about residual insulin secretion in IDDM (7, 20, 21) .
At prestimulatory normoglycemia, blood glucose as well as plasma C-peptide showed a persistent increase within 2 h after the start of the meal, at which time blood sampling was stopped. In the present protocol, we stopped blood sampling after 2 h because previous studies have shown that peak plasma C-peptide occurs on the average 2 h after the start of a standard meal in patients with IDDM (1) . Furthermore, in the same study, the incremen-tal area under the curve to plasma C-peptide within 2 h after the meal correlated closely to the incre¬ mental area obtained within 4 h after the start of the meal (r=0.99, p<0.01, N=17). Thus, it is an acceptable assumption that the incremental C-pep¬ tide area under the curve within 2 h after the start of the meal is representative of the total area under the curve. The increment in blood glucose concen¬ tration during the meal at prestimulatory hypergly¬ cemia was lower than the increment at prestimula¬ tory normoglycemia. The reason for the lower in¬ crement in blood glucose concentration probably was the enhanced insulin secretion in combination with an improvement in insulin sensitivity (11) . A further explanation could be an enhanced glucosuria during the meal at hyperglycemia. Urinary glucose excretion was, however, not measured during the study. Despite the low increment in blood glucose concentration, prestimulatory hy¬ perglycemia induced a significant potentiation of the plasma C-peptide response to the meal of a similar magnitude as the potentiation of the C-pep¬ tide response to glucagon.
During the meal, the ratio between plasma proinsulin and plasma C-peptide showed a signif¬ icant increase, whereas this was not the case after stimulation with glucagon. Similar findings were reported in patients with NIDDM (12) . Thus, the islet B-cells seem to be forced to secrete immature granules during the meal, suggesting that the B-cells are under more stress after the meal than after glucagon.
In conclusion, the plasma C-peptide response to iv glucagon or to a standard mixed meal is poten¬ tiated considerably by acutely established hypergly¬ cemia in IDDM. However, no further potentiation seems to be induced when prestimulatory blood glucose concentration is raised above 12 mmol/1.
